Uniqueness of Solutions to Compartmental Models of Population Pharmacokinetics for Drugs Undergoing Complex Metabolism

Uniqueness of Solutions to Compartmental Models of Population Pharmacokinetics for Drugs Undergoing Complex Metabolism

Conference: ASCPT

To investigate parameter identifiability and uniqueness of solutions to compartmental population pharmacokinetic (PPK) models for drugs with complex metabolism.

Comparison of Linezolid Pharmacokinetics from Phase I Studies of Japanese and Caucasians

Comparison of Linezolid Pharmacokinetics from Phase I Studies of Japanese and Caucasians

Conference: ASCPT

This bridging analysis compared pharmacokinetic (PK) parameters for linezolid (lzd) observed in Japanese (J) and Caucasians (C) in traditional PK Phase I studies.

Pharmacodynamics in the evaluation of drug regimens

Pharmacodynamics in the evaluation of drug regimens

Publication: Ann Pharmacother

We believe, especially in an era of increasing antimicrobial resistance, that the integration of PK/PD models and stochastic techniques provides a powerful new tool...

Population Pharmacodynamic (PD) Assessment of the Safety and Antiretroviral Activity of Atazanavir (BMS-232632)

Population Pharmacodynamic (PD) Assessment of the Safety and Antiretroviral Activity of Atazanavir (BMS-232632)

Conference: ICAAC

Atazanavir (BMS-232632), currently in Phase III development, is a well-tolerated, once-daily protease inhibitor (PI) which does not appear to elevate cholesterol or triglyceride blood levels and has…

Population Pharmacokinetics/Pharmacodynamics of Antidepressant R,R(-) and S,S(+) Reboxetine (RBX)

Population Pharmacokinetics/Pharmacodynamics of Antidepressant R,R(-) and S,S(+) Reboxetine (RBX)

Conference: AAPS

To develop a population pharmacokinetic model describing the disposition of each enantiomer of antidepressant reboxetine and a pharmacodynamic model relating plasma concentrations and adverse effects.

Predicting the impact of physiological and biochemical processes on oral drug bioavailability

Predicting the impact of physiological and biochemical processes on oral drug bioavailability

Publication: Adv Drug Deliv Rev
Software: GastroPlus®
Division: PBPK

Recent advances in computational methods applied to the fields of drug delivery and biopharmaceutics will be reviewed with a focus on prediction of the impact of physiological and biochemical factors on...

A New Paradigm in Pediatric Drug Development: The Application of Cognitive Engineering

A New Paradigm in Pediatric Drug Development: The Application of Cognitive Engineering

Conference: DIA

Design of clinical trials in pediatrics is complicated by sensitive ethical considerations, a small pool of appropriate study subjects, and difficulty in determining drug dosing regimens. Cognitive engineering…

Transcend Global and Corporate Boundaries During Drug Development

Transcend Global and Corporate Boundaries During Drug Development

Conference: DIA

We developed an innovative and alternative web-based strategy which combines a hypertext environment with human intelligence and creativity to lead a scientific audience through complex statistical…

Integrating Real-Time Data Assembly (RTDA) and Population Pharmacokinetics as Tactical Components of Cognitive Engineering

Integrating Real-Time Data Assembly (RTDA) and Population Pharmacokinetics as Tactical Components of Cognitive Engineering

Conference: DIA

The goal of drug development is to produce a safe and efficacious drug that will thrive in a competitive marketplace. Cognitive engineering couples technology and human intelligence to generate and use…

Ties in Proximity and Clustering Compounds

Ties in Proximity and Clustering Compounds

Publication: J Chem Inf Model
Software: MedChem Studio™

Hierarchical clustering algorithms such as Wards or complete-link are commonly used in compound selection and diversity analysis. Many such applications utilize binary representations of chemical structures...